Finance
HHS Secretary Alex Azar on drug pricing
- Health and Human Services Secretary Alex Azar isn’t counting
on pharmaceutical companies to do the right thing when it comes
to drug prices. - “I’m not counting on their altruism or their cooperation,”
Azar said at the Financial Times’ Pharma Pricing Summit on
Thursday.
Department of Health and Human Services Secretary Alex Azar isn’t
banking on the pharmaceutical industry to fix the rising cost of
prescription drugs in the US.
“I’m not counting on their altruism or their cooperation,” Azar
said at the Financial Times’ Pharma Pricing Summit on Thursday.
“We’re going to change the rules of the road to make enduring
changes to the incentive systems built into the channel.”
The Trump administration has been vocal about lowering drug
prices in the US, coming to a head in July when President Donald
Trump
singled out pharma giant Pfizer for its price increases.
Shortly after, Pfizer and a number of major pharmaceutical
companies made various commitments not to increase the price of
its
medications until 2019. US pharma giant Merck went so
far as to lower the prices of
some of its medications.
In May, the Trump administration laid out
a
44-page
drug-pricing blueprint,
calling out middlemen in
the pharmaceutical industry and “freeloading” by other countries
that pay less than the US for prescription drugs. Azar said
Thursday that it’ll take time for some of the regulations coming
out of that blueprint to take effect.
One of the areas he’s focused on, he said, are the rebates
pharmaceutical companies negotiate with those middlemen. The way
he sees it, rebates are leading to higher list
prices.
“The rebate system we have is a constant incentive to
higher list prices,” Azar said.
Azar’s no stranger to the pharmaceutical industry. Prior to
joining the Trump administration, he served as a senior
executive at Eli Lilly, a pharmaceutical company based in
Indianapolis.
See also:
-
Business7 days ago
Humanoid robots are learning to fall well
-
Entertainment6 days ago
2024 summer TV preview: 33 TV shows to watch this summer
-
Business6 days ago
Google Gemini: Everything you need to know about the new generative AI platform
-
Business4 days ago
Haun Ventures is riding the bitcoin high
-
Entertainment5 days ago
‘Bridgerton’: Everything you need to remember before Season 3
-
Entertainment4 days ago
Hands-on with the Claude AI app: It’s pleasant to use, but janky
-
Entertainment3 days ago
5 essential gadgets for turning your home into a self-care sanctuary
-
Business6 days ago
Indian ride-hailing giant Ola cuts 180 jobs in profitability push